For Esperion Therapeutics, 2024 has marked a pivotal transformation in its mission to combat cardiovascular disease. | ...

Deaths from cardiovascular disease have surged among adults ages 25 to 64 living in rural areas, a new study shows.

Salk scientists have tracked the flow of trans fats using mouse models to describe the molecular mechanisms that cause trans fats to promote atherosclerotic cardiovascular disease (ASCVD), explaining ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

Among the common but lesser-known consequences of intimate partner violence is a heightened risk for cardiovascular disease.

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...

Shared genetic factors may drive both osteoarthritis and cardiovascular disease, suggesting a common genetic basis that ...

A new study has revealed that the shape of the heart is influenced in part by genetics and may help predict the risk of cardiovascular diseases.

Researchers sought to determine the relationship between sleep duration and clinical depression in patients with cardiovascular disease.

Professor Allan Lawrie discusses the future of personalised cardiovascular disease detection and monitoring and wearable ...